HIKMA PHARMACEUTICALS PLC (HKMPF:OTCMKTS)
$21.56 0.31 (1.4588%)
Analysed HIKMA PHARMACEUTICALS PLC (HKMPF:OTCMKTS) News Sources
One Hikma Pharmaceuticals Insider Raised Stake By 14% In Previous Year
10-08-2025
yahoo.com
How the Narrative Around Hikma Pharmaceuticals Is Shifting After Recent Analyst Target Moves
15-12-2025
yahoo.com
Hikma Pharmaceuticals (LON:HIK) shareholders have endured a 29% loss from investing in the stock five years ago
07-01-2026
yahoo.com
What Analysts Think Is Changing The Story For Hikma Pharmaceuticals (LSE:HIK)
06-02-2026
yahoo.com
Hikma comments on Supreme Court of the United States' unanimous decision in favour of Hikma
04-06-2026
yahoo.com
Hikma recovery story still has further to run after recent rally, says Panmure
22-07-2026
proactiveinvestors.com
Hikma and Fresenius best positioned from Trump's generic drug tariffs, says Citi
23-07-2026
proactiveinvestors.com
Citi starts Hikma at 'buy' with strategy reset offering compelling entry point
16-07-2026
proactiveinvestors.com
What is the current price of HIKMA PHARMACEUTICALS PLC (HKMPF:OTCMKTS)?
The current price of HIKMA PHARMACEUTICALS PLC (HKMPF:OTCMKTS) is $21.56.
HIKMA PHARMACEUTICALS PLC (HKMPF:OTCMKTS) absolute price change since previous trading day?
The absolute price change of HIKMA PHARMACEUTICALS PLC (HKMPF:OTCMKTS) since the previous trading day is $0.31.
HIKMA PHARMACEUTICALS PLC (HKMPF:OTCMKTS) percentage price change since previous trading day?
The percentage price change of HIKMA PHARMACEUTICALS PLC (HKMPF:OTCMKTS) since the previous trading day is 1.4588%.
What is the most recent average sentiment score for HIKMA PHARMACEUTICALS PLC (HKMPF:OTCMKTS)?
The most recent average sentiment score for HIKMA PHARMACEUTICALS PLC (HKMPF:OTCMKTS) is 82 out of 100.
What is the most recent average sentiment for HIKMA PHARMACEUTICALS PLC (HKMPF:OTCMKTS)?
The most recent sentiment for HIKMA PHARMACEUTICALS PLC (HKMPF:OTCMKTS) is .
SEC-8K** Filing Available For HIKMA PHARMACEUTICALS PLC (HKMPF:OTCMKTS)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.